The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a

The Cooper Companies, Inc. (COO) Revenue

Alert me on Revenue

The Cooper Companies, Inc.'s revenue for fiscal 2025 was $4.1B, up 5.06% from $3.9B in fiscal 2024. Over the twelve months to 31 July 2026 it was $4.2B. Over the past ten years it has ranged from $1.8B (fiscal 2015) to $4.1B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. The Cooper Companies, Inc. ranks 10th of 50 Medical Instruments & Supplies companies by revenue.

Revenue, annual

Embed this chart

Annual newest first

Period Revenue Change
FY2025 $4.1B 5.06%
FY2024 $3.9B 8.41%
FY2023 $3.6B 8.61%
FY2022 $3.3B 13.20%
FY2021 $2.9B 20.22%
FY2020 $2.4B (8.39%)
FY2019 $2.7B 4.76%
FY2018 $2.5B 18.41%
FY2017 $2.1B 8.76%
FY2016 $2.0B 9.44%

Quarterly newest first

Period Revenue Change
Jul 2026 $1.1B (1.41%)
Apr 2026 $1.1B 5.60%
Jan 2026 $1.0B (3.85%)
Oct 2025 $1.1B 0.45%
43 more quarters

Against its own ten years

Low $1.8B High $4.1B
Ten-year median $2.7B
Current reading's percentile 100

Revenue against peers

What Revenue is

Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.

Reported line item

The full definition of Revenue →

More on COO